CanBas Co.
Latest round
- Series D
Last raised
- Nov 2005
Total raised
- $20M
Investors
- 7
About CanBas Co.
, Ltd., Ltd. is headquartered in Numazu, Japan and specializes in cancer therapeutics development.8 mn in an IPO on September 17, 2009, securing its position in the oncology sector., Ltd. specializes in the research and development of innovative cancer therapeutics, focusing on immuno-oncology products. Their core offerings include flagship drug candidates CBP501, an immune igniter, and CBS9106, a reversible XPO1 inhibitor, designed to enhance the body’s immune response against tumors. These products are aimed at treating various cancers and are intended for clinical use to improve patient outcomes.60., Ltd. The company is focusing on advancing its new products through upcoming clinical trials and aims to establish direct sales to healthcare providers once its products receive regulatory approval, thereby creating a robust income stream from their proprietary cancer therapies.
Who invested in CanBas Co.
7 investors across 1 round
See all investors in CanBas Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Nov 30, 2005
Amount
$20M
Investors
Questions about CanBas Co.
Who invested in CanBas Co.?
CanBas Co. has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CanBas Co. raised?
CanBas Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CanBas Co. last raise money?
CanBas Co.'s most recent round on record is a Series D, in Nov 2005.
What does CanBas Co. do?
CanBas Co. is a pharmaceuticals company.
Where is CanBas Co. headquartered?
CanBas Co. is headquartered in Numazu, Japan.
Which VCs invest in companies like CanBas Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at CanBas Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like CanBas Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.